Literature DB >> 7606834

Gastrin-physiological and pathophysiological role: clinical consequences.

H L Waldum1, E Brenna, P M Kleveland, A K Sandvik.   

Abstract

Gastrin plays a central role in the regulation of acid secretion. It is released by meals in quantities sufficient to explain meal-stimulated acid secretion. Gastrin stimulates acid secretion mainly by releasing histamine from the enterochromaffin-like (ECL) cell. Whether gastrin has any functional direct effect on the parietal cell remains to be shown. Gastrin stimulates not only the function but also the growth of the ECL cell, and long-term hypergastrinemia may lead to ECL cell carcinoids. The role of the ECL cell in human gastric carcinogenesis is controversial, but it seems wise to avoid long-term iatrogen hypergastrinemia especially in young persons. Interestingly, the oxyntic mucosal D cell, on which gastrin has a negative trophic effect, may play a role in gastric stump carcinoma, and thus hypogastrinemia may also dispose to gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606834     DOI: 10.1159/000171484

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

1.  Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine.

Authors:  Reidar Alexander Vigen; Mark Kidd; Irvin M Modlin; Duan Chen; Chun-Mei Zhao
Journal:  Med Mol Morphol       Date:  2012-06       Impact factor: 2.309

2.  Marked increase in gastric acid secretory capacity after omeprazole treatment.

Authors:  H L Waldum; J S Arnestad; E Brenna; I Eide; U Syversen; A K Sandvik
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

3.  Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.

Authors:  Giammarco Fava; Sharon Demorrow; Eugenio Gaudio; Antonio Franchitto; Paolo Onori; Guido Carpino; Shannon Glaser; Heather Francis; Monique Coufal; Luca Marucci; Domenico Alvaro; Marco Marzioni; Trenton Horst; Romina Mancinelli; Antonio Benedetti; Gianfranco Alpini
Journal:  Liver Int       Date:  2009-03-09       Impact factor: 5.828

Review 4.  New molecular targets for treatment of peptic ulcer disease.

Authors:  Frank Lehmann; Pius Hildebrand; Christoph Beglinger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells.

Authors:  E Hofsli; L Thommesen; F Yadetie; M Langaas; W Kusnierczyk; U Falkmer; A K Sandvik; A Laegreid
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

Review 6.  Relationship of ECL cells and gastric neoplasia.

Authors:  H L Waldum; E Brenna; A K Sandvik
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 7.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

Review 8.  The Phylogeny and Biological Function of Gastric Juice-Microbiological Consequences of Removing Gastric Acid.

Authors:  Tom C Martinsen; Reidar Fossmark; Helge L Waldum
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.